State updates - 04/17/2026

California

AB 1990 cleared the Business & Professions Committee on April 14 with a “do pass as amended” vote, advancing it to the Committee on Privacy and Consumer Protection, where it has a hearing scheduled for April 21. APC Board Vice President Peter Koshland testified in Sacramento this week in opposition, pushing back on misinformation and keeping the discussion grounded in real-world impact. We’re grateful for his time and advocacy.

The bill would restrict compounding of GLP-1 medications in ways we’ve seen attempted in other states this year, and this fight isn’t over. If you’re based in California or serve patients or prescribers there, there’s still time to make your voice heard before the April 21 hearing. Send a message to your Assembly member urging them to oppose AB 1990 – it takes just 30 seconds.

Colorado

SB 26-066 has been laid over again, this time until Friday, April 17, when it’s scheduled for its third reading in the Senate. Whether that actually happens remains to be seen – this bill has made a habit of delays.

Kentucky

The Kentucky General Assembly adjourned its 2026 session this week and HB 729 died with it. Dubbed "Jimmie's Law," this bill was aimed at unlicensed entities operating outside the regulated pharmacy system more than at legitimate compounding pharmacies. It applied broadly to all compounded drugs, not just GLP-1s, and would have introduced new permitting requirements, expanded inspection authority, and criminal penalties for certain compounding violations. APC is seeking a few amendments, and we’re hopeful we can find a way to support it when it returns next session.